A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignanciesVON MEHREN, M; SCHILDER, R. J; CHENG, J. D et al.Annals of oncology. 2008, Vol 19, Num 10, pp 1802-1809, issn 0923-7534, 8 p.Article

A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimensKRASNER, C. N; MCMEEKIN, D. S; CHAN, S et al.British journal of cancer. 2007, Vol 97, Num 12, pp 1618-1624, issn 0007-0920, 7 p.Article